| Connecticut Surgical Group, Pc | |
|
29 Haynes St, Manchester, CT 06040-4139 | |
| (860) 547-0616 | |
| (860) 524-2655 |
| Full Name | Connecticut Surgical Group, Pc |
|---|---|
| Type | Facility |
| Speciality | Durable Medical Equipment & Medical Supplies |
| Location | 29 Haynes St, Manchester, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952589434 | NPI | - | NPPES |
| 01926310 | Medicaid | NY | |
| 004139350 | Medicaid | CT | |
| 004169711 | Medicaid | CT | |
| 004201034 | Medicaid | CT | |
| 9781188 | Medicaid | MA | |
| 50CONNSURG01 | Other | CT | ANTHEM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | (* (Not Available)) | Secondary |
| 332B00000X | Durable Medical Equipment & Medical Supplies | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Connecticut Surgical Group, Pc 17 Talcott Notch Rd, Farmington, CT 06032-1818 Ph: (860) 547-0616 | Connecticut Surgical Group, Pc 29 Haynes St, Manchester, CT 06040-4139 Ph: (860) 547-0616 |
News Archive
Bruker today announces the launch of the new INVENIO™ Fourier Transform Infrared (FT-IR) research spectrometer. The INVENIO is the successor to the renowned VERTEX 70 FT-IR for advanced R&D applications.
Results of a landmark, seven-year National Institutes of Health-funded trial, Management of Myelomeningocele Study (MOMS), demonstrate clear benefit for babies who undergo fetal surgery to treat spina bifida, the most common birth defect in the central nervous system.
The number of obese Americans is expected to increase to 113 million by the year 2022, making the U.S. the most overweight country in the world.
Paratek Pharmaceuticals, Inc. announced today that it has entered into an exclusive worldwide collaborative development, manufacturing and commercialization license agreement with Novartis for Paratek's lead broad-spectrum antibiotic, PTK 0796, a first-in-class aminomethylcycline (AMC) in Phase 3 clinical trials.
The Knowledge-Driven International Development (KDID) Portal's "Agrilinks" blog features a summary of several of the speakers who presented at the Feed the Future Forum, including Peter McPherson, president of the Association of Public and Land Grant Universities;
› Verified 5 days ago